PDCO minutes of the 21-24 April 2026 meeting

EMA/PE/0000232765

PSUSA/00010508/202509

Human medicines European public assessment report (EPAR): Kostaive, zapomeran, Date of authorisation: 12/02/2025, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Ameluz, 5-aminolevulinic acid hydrochloride, Date of authorisation: 13/12/2011, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Xeplion, paliperidone, Date of authorisation: 04/03/2011, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Namuscla, Mexiletine, Date of authorisation: 18/12/2018, Revision: 9, Status: Authorised

Development of a reflection paper on the use of external controls for evidence generation in regulatory decision-making - Scientific guideline

Biltricide

Insuman Basal and Comb 25